Scoop has an Ethical Paywall
Statement of Preliminary Issues released for GSK application
The Commerce Commission has published a statement of preliminary issues relating to an application from GlaxoSmithKline plc seeking clearance to acquire the consumer healthcare business of Pfizer Inc.
The statement outlines the key competition issues that the Commission considers important in deciding whether or not to grant clearance to the proposed acquisition.
The Commission invites interested parties to provide comments on the likely competitive effects of the proposed acquisition. Submissions can be sent by email to registrar@comcom.govt.nz with the reference GSK/Pfizer in the subject line. Parties should provide a public version of their submission at the same time for publication on the Commission’s case register. Any submissions should be received by close of business on Wednesday 3 April 2019.
The Commission is currently
scheduled to make a decision on the application by 7 May
2019. However, this date may be extended as the
investigation progresses.
The Statement of Preliminary
Issues and a public version of the application can be found
on the on the Commission’s case
register.
John Mazenier: Gaffer Tape And Glue Delivering New Zealand’s Mission Critical Services
Earthquake Commission: Ivan Skinner Award Winner Inspired By Real-life Earthquake Experience
Reserve Bank: Consultation Opens On A Digital Currency For New Zealand
NIWA: Ship Anchors May Cause Extensive And Long-lasting Damage To The Seafloor, According To New Research
New Zealand Customs Service: A Step Forward For Simpler Trade Between New Zealand And Singapore
Horizon Research: 68% Say Make Banks Offer Fraud Protection
